We propose an automated method for the routineanalysis of urinary iodide, using paired-ion reversed-phase HPLC with electrochemical detection and a silver working electrode. Assay 
IndexingTerms: colorimetry compared/total iodine vs unbound iodide
The determination of urinary iodine concentration is a valuable tool in epidemiological studies of iodine supplementation (1) (2) (3) (4) (5) (6) , particularly in diagnosing iodine deficiency (7) and controlling goiter (8). Because of the difficulty of measuring dietary iodine intake directly, urinary iodine concentrations are usually used as an index of iodine intake.
In healthy individuals, fecal iodine excretion is negligible (9).
Several methods are available
for determining iodine in biological fluids (10) (11) (12) (13) . At present, the most common techniques are the colorimetric ceric-araenic assays (14-21), which are based on the catalytic effect of iodide in the redox reaction between yellow cerium(lV) and arsenic(ffl), to yield the colorless cerium(HI) and arsenic(V) (22, 23 NaC1, NaBr, NaF, Na2S, Na2SO3, Na2S2O3 . 5H20, NaNO2, NaNO3, KSCN, KCN, disodium oxalate, and oxalic acid were obtained from Merck.
Mobile Phase
The mobile phase consisted of 10
and 6 mmol/L di-n-butylamine in HPLC-grade I water. The pH of the resulting mobile phase was adjusted to 7.0 with 85% orthophosphoric acid (H3P04). Before use, the mobile phase was filtered through a 0.45-pm-pore membrane filter (Waters) and degassed under reduced pressure.
Procedures
Collection of urine samples. We collected 177 random urine samples from 48 patients who underwent, in different groups, three kinds of medical treatment for diffuse goiter (pure iodide, pure levothyroxine, and a combination of both). The daily amount of iodide administered was 100-500 g (mean 230); levothyroxine, 100-150 g (mean 130); and 1.0 or 1.5 tablets of a formulation consisting of 100 g iodide and 100 g of levothyroxine.
The study was approved by the Institutional Review Board, and written informed consent was given by all patients. Random (untimed) urine samples were taken before the start of therapy and 3, 6, and 12 months afterwards. from the analyte concentration at which the withinassay CV in the precision proffle is 10% (Fig. 3) .
Precision. The precision proffle is based on 10 determinations each of nine urine samples containing different amounts of iodine. As shown (Fig. 3) the CV was Technicon UU iodide, pmol/L The present study compares for the first time data from random urine samples measured for iodine concentration by both HPLC and the AutoAnalyzer.
As expected, there is almost complete agreement between the amount of iodine in the sample eluates and the amount of corresponding unbound urinary iodide, because the organically bound iodine is removed by sample preparation. Good agreement is also achieved for untreated specimens measured with the AutoAnalyzer and eluates from the same samples measured by HPLC. This is equivalent to comparing total urinary iodine with unbound urinary iodide. High correlation is seen here too, but the regression coefficient differs from 1, given that urinary inorganic iodide is not completely identical with the total amount of iodine in urine. The HPLC method therefore slightly underestimates the total amount of iodine excreted in urine.
Recovery and precision data for the two methods are also in close agreement.
Moreover, the detection threshold of 0.04 mol/L of the HPLC system does not differ from the least iodine concentration detectable by the AutoAnalyzer (7, 23).
In conclusion, the present study clearly demonstrates that HPLC with electrochemical detection with a silver electrode is a relatively simple, precise, and accurate method for determining urinary iodide concentrations. 
